I do not doubt for one minute the treatments. Nor do I

New Post Public Reply Private Reply Replies (0) Message Board
patientgal herbster #3755
I do not doubt for one minute the treatments. Nor do I doubt that they will receive FDA approval. I just don't. I have always maintained that. However, the state that BMSN will be in when approval does arrive, is something I can only speculate about. I have made it clear that I believe Koos is responsible in more ways than one, for this stock being decimated as it has all this time. Given the market potential of the treatments and the doctors that have worked so hard to see them ultimately come to fruition, there is no excuse for the way Koos has conducted business. Especially since he has all this business experience under his belt. None. 

It could be months before the FDA renders their decision. Maybe not. Who in the world knows now with the state of affairs that are upon us. If it does take many more months and this "chief" continues to operate as he has thus far, is there anything that indicates the stock will be worth nothing when at last it does come? The market potential for Hema pales to that of the dCellvax. No new IND applications are being accepted even if it is ready to be submitted. So, what is the plausible wait for this once it is finally accepted for consideration? How much more will he dilute?

Unless this "chief" shows some concern for his shareholders (most likely something insisted upon by his medical team and certainly not of his own free will I have no doubt) AND some actual business savvy, your guess is as good as mine where this stock will be in the future. Though, if history speaks for itself, well...you already know the answer.

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 5

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading

Top 5 Most Recently Viewed Articles

Comprehensive Overview of Marlowe PLC's Latest Disclosure

Updated Category News Views 133

Understanding the Disclosure from Marlowe PLC The public opening position disclosure from Marlowe PLC brings vital information to investors and stakeholders. It serves as an essential document under the rules established by the Takeover Code. A disclosure like this outlines the interests stakeholders hold in relevant securities, especially when they represent 1% or...

Continue Reading
Harvard Extension School's Social Media Triumph at UPCEA

Updated Category News Views 210

Harvard Extension School's #HESProud Campaign Achievements The Harvard Extension School (HES) proudly announces its victory with the #HESProud social media campaign, honored as the GOLD recipient of the UPCEA's Excellence in Marketing Award for 2024. This notable accolade it received celebrates the campaign's creativity and engagement, which resonated significantly across...

Continue Reading
AI in CX: The Gap Between Hype and Reality

Updated Category News Views 5

AI in Customer Experience: Not Quite There Yet Let's dive into what TELUS Digital and Ryan Strategic Advisory's survey reveals: enterprises are tossing AI into their customer experience (CX) operations like confetti, yet they're fumbling when it comes to actually tracking if it’s doing any good. Most are relying on human agents propped up by AI, with a solid 61% rolling...

Continue Reading
Humana and Longevity Health Team Up to Boost Medicare Access

Updated Category News Views 108

Humana and Longevity Health Join Forces for Expanded Access In an important alliance, Humana Inc. (NYSE: HUM) and Longevity Health have unveiled a multi-state initiative set to enhance accessibility to Humana Together in Health, which is a Medicare Advantage Institutional Special Needs Plan (I-SNP). This collaboration focuses on providing personalized care to individuals...

Continue Reading
Key Ruling in Niger Delta Oil Pollution Issue by High Court

Updated Category News Views 299

Groundbreaking Judgment in Niger Delta Oil Pollution Case In a significant ruling, the English High Court addressed ongoing litigation regarding oil pollution in the Niger Delta, focusing specifically on the Bille and Ogale regions. This decision, delivered by Justice May, aims to clarify complex legal issues and streamline the upcoming trial process. Facing off in this...

Continue Reading